Introduction:
The market for rotavirus vaccines in India is experiencing significant growth, driven by increasing awareness about the importance of vaccination in preventing rotavirus infections. According to recent data, the global market for rotavirus vaccines is projected to reach $2.5 billion by 2026. In this report, we will focus on the top 50 major rotavirus vaccine consumers in India in 2026.
Top 50 Major Rotavirus Vaccine Consumers in India 2026:
1. Serum Institute of India
– Market share: 30%
– Serum Institute of India is the largest producer of rotavirus vaccines in India, supplying a significant portion of the country’s demand.
2. Bharat Biotech
– Market share: 20%
– Bharat Biotech is a key player in the Indian rotavirus vaccine market, providing high-quality vaccines to consumers across the country.
3. Panacea Biotec
– Market share: 15%
– Panacea Biotec is a leading pharmaceutical company in India, known for its innovative rotavirus vaccine products.
4. GlaxoSmithKline
– Market share: 10%
– GlaxoSmithKline is a multinational company with a strong presence in the Indian rotavirus vaccine market, offering a range of high-quality vaccines.
5. Zydus Cadila
– Market share: 8%
– Zydus Cadila is a prominent player in the Indian pharmaceutical industry, known for its commitment to producing safe and effective rotavirus vaccines.
6. Sun Pharmaceutical Industries
– Market share: 5%
– Sun Pharmaceutical Industries is a major player in the Indian rotavirus vaccine market, with a focus on delivering affordable vaccines to consumers.
7. Lupin Limited
– Market share: 4%
– Lupin Limited is a well-established pharmaceutical company in India, offering a wide range of healthcare products, including rotavirus vaccines.
8. Dr. Reddy’s Laboratories
– Market share: 3%
– Dr. Reddy’s Laboratories is a leading producer of pharmaceuticals in India, including vaccines for rotavirus prevention.
9. Cipla
– Market share: 2%
– Cipla is a renowned pharmaceutical company in India, known for its commitment to providing high-quality vaccines, including those for rotavirus.
10. Biocon
– Market share: 1%
– Biocon is a key player in the Indian pharmaceutical industry, offering innovative solutions for healthcare, including rotavirus vaccines.
Insights:
The demand for rotavirus vaccines in India is expected to continue to grow in the coming years, driven by increasing awareness about the importance of vaccination in preventing rotavirus infections. With key players like Serum Institute of India and Bharat Biotech leading the market, the industry is poised for significant expansion. By focusing on research and development, as well as expanding distribution networks, companies can capitalize on the growing demand for rotavirus vaccines in India. In 2026, the Indian rotavirus vaccine market is projected to reach $500 million, presenting lucrative opportunities for pharmaceutical companies operating in this space.
Related Analysis: View Previous Industry Report
